Hiroki Odagiri

1.6k total citations
36 papers, 1.3k citations indexed

About

Hiroki Odagiri is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Hiroki Odagiri has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Hiroki Odagiri's work include Cancer Treatment and Pharmacology (13 papers), Colorectal Cancer Treatments and Studies (8 papers) and HER2/EGFR in Cancer Research (5 papers). Hiroki Odagiri is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Colorectal Cancer Treatments and Studies (8 papers) and HER2/EGFR in Cancer Research (5 papers). Hiroki Odagiri collaborates with scholars based in Japan, United States and United Kingdom. Hiroki Odagiri's co-authors include Kiyoshi Miyagawa, Teruhiko Yoshida, M Terada, Michael S. German, Takashi Sügimura, Hideo Sakamoto, Peter Little, Daigo Yamamoto, Satoru Iwase and Thai‐Yen Ling and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hiroki Odagiri

33 papers receiving 1.3k citations

Peers

Countries citing papers authored by Hiroki Odagiri

Since Specialization

Citations

This map shows the geographic impact of Hiroki Odagiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Odagiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Odagiri more than expected).

Fields of papers citing papers by Hiroki Odagiri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Odagiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Odagiri. The network helps show where Hiroki Odagiri may publish in the future.

Co-authorship network of co-authors of Hiroki Odagiri

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Odagiri. A scholar is included among the top collaborators of Hiroki Odagiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Odagiri. Hiroki Odagiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Three Cases of Pulmonary Aspergillosis Complicating Unilateral Upper Lung Field Pulmonary Fibrosis After Thoracotomy 2025 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hiroki Odagiri, Tomoki Akita, (unknown), Hiroaki Sakamoto, (unknown), Masamichi Itoga, Tomonori Makiguchi, Hisashi Tanaka, Kageaki Taima, Sadatomo Tasaka	0
2	Evidence-Based Practice Guideline for the Management of Lymphedema Proposed by the Japanese Lymphedema Society 2022 ·Lymphatic Research and Biology ·Kaoru Kitamura, Satoru Iwase, Yoshifumi Komoike, Yoshinari Ogawa, Kuniko Utsugi, Daigo Yamamoto, Hiroki Odagiri	6
3	Japanese translation and linguistic validation of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) 2017 ·Journal of Patient-Reported Outcomes ·Tempei Miyaji, (unknown), Yujiro Kuroda, Daigo Yamamoto, Satoru Iwase, Yasushi Goto, Masahiro Tsuboi, Hiroki Odagiri, (unknown), Takashi Kawaguchi, (unknown), Ethan Basch, Takuhiro Yamaguchi	168
4	Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial 2015 ·Cancer Chemotherapy and Pharmacology ·Daigo Yamamoto, Satoru Iwase, (unknown), Keisuke Ariyoshi, Takashi Kawaguchi, Tempei Miyaji, (unknown), Chizuko Yamamoto, (unknown), Hiroki Odagiri, Kenichiro Kitamura, (unknown), Takuhiro Yamaguchi	11
5	Efficacy of meloxicam in combination with preoperative chemotherapy for breast cancer - Japan Breast Cancer Research Network (JBCRN) 02-1 trial. 2011 ·PubMed ·Daigo Yamamoto, Satoru Iwase, Hideyuki Yoshida, Yujiro Kuroda, Chizuko Yamamoto, Kaoru Kitamura, Hiroki Odagiri, (unknown)	6
6	Efficacy of Vitamin E Treatment for Hand-Foot Syndrome in Patients Receiving Capecitabine 2010 ·Breast Care ·Daigo Yamamoto, Chizuko Yamamoto, Satoru Iwase, Yujiro Kuroda, Hiroki Odagiri, (unknown)	11
7	Anti-apoptotic effect of claudin-1 in tamoxifen-treated human breast cancer MCF-7 cells 2010 ·BMC Cancer ·Harue Akasaka, Fuyuki Sato, Satoko Morohashi, Yunyan Wu, Yang Liu, Jun Kondo, Hiroki Odagiri, Kenichi Hakamada, Hiroshi Kijima	38
8	A CASE OF PINCH-OFF SYNDROME IN ADJUVANT CHEMOTHERAPY FOR BREAST CANCER 2008 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Daisuke Kudo, (unknown), (unknown), Hiroki Odagiri, Kenichi Hakamada	0
9	Decreased expression of claudin-1 correlates with recurrence status in breast cancer 2007 ·International Journal of Molecular Medicine ·Satoko Morohashi, Tomomi Kusumi, Fuyuki Sato, Hiroki Odagiri, Hiroki Chiba, Shuichi Yoshihara, Kenichi Hakamada, Mutsuo Sasaki, Hiroshi Kijima	111
10	Complete remission of recurrent breast cancer with multiple liver metastases after oral capecitabine and injected trastuzumab 2007 ·Breast Cancer ·Satoko Morohashi, Hiroki Odagiri, Hajime Morohashi, Yutaka Kimura, Mutsuo Sasaki	1
11	A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial 2007 ·Cancer Chemotherapy and Pharmacology ·Daigo Yamamoto, Satoru Iwase, Kaoru Kitamura, Hiroki Odagiri, Chizuko Yamamoto, (unknown)	40
12	A new method to immortalize primary cultured rat hepatocytes 2004 ·Transplantation Proceedings ·(unknown), Hiroki Odagiri, Eishi Totsuka, Mutsuo Sasaki	3
13	Chemosensitivity of human pancreatic carcinoma cells is enhanced by IkBα super‐repressor 2003 ·Cancer Science ·Toshiyuki Sato, Hiroki Odagiri, (unknown), (unknown), Mutsuo Sasaki	19
14	Aberrantly expressed recoverin is functionally associated with G-protein-coupled receptor kinases in cancer cell lines 2003 ·Biochemical and Biophysical Research Communications ·Yasuhiro Miyagawa, Hiroshi Ohguro, Hiroki Odagiri, Ikuyo Maruyama, Tadao Maeda, Akiko Maeda, Mutsuo Sasaki, Mitsuru Nakazawa	23
15	Upregulation of α‐synuclein by lipopolysaccharide and interleukin‐1 in human macrophages 2002 ·Pathology International ·Kunikazu Tanji, Fumiaki Mori, Tadaatsu Imaizumi, Hidemi Yoshida, Tomoh Matsumiya, Wakako Tamo, Makoto Yoshimoto, Hiroki Odagiri, Mutsuo Sasaki, Hitoshi Takahashi, Kei Satoh, Koichi Wakabayashi	45
16	Function of the Human Insulin Promoter in Primary Cultured Islet Cells 1996 ·Journal of Biological Chemistry ·Hiroki Odagiri, Juehu Wang, Michael S. German	68
17	[Clinical evaluation of four tumor markers (CEA, TPA, CA50 and CA72-4) in colorectal cancer]. 1992 ·PubMed ·Fumiaki Koizumi, Hiroki Odagiri, Hiroyuki Fujimoto, (unknown), (unknown)	5
18	Determination of 5-fluorouracil in plasma and liver after oral administration of 5'-deoxy-5-fluorouridine using gas chromatography-mass spectrometry. 1988 ·Journal of Pharmacobio-Dynamics ·Hiroki Odagiri, Shigeyasu Ichihara, (unknown), Masahiro Utoh, Mitsuru Tateishi, Isami Kuruma	13
19	Cloned hst gene from normal human leukocyte DNA transforms NIH3T3 cells 1988 ·Biochemical and Biophysical Research Communications ·Hiromi Sakamoto, Teruhiko Yoshida, (unknown), Hiroki Odagiri, Kiyoshi Miyagawa, Takashi Sügimura, Masaaki Terada	34
20	A case of huge rectal prolapse with advanced cancer. 1984 ·Nihon Daicho Komonbyo Gakkai Zasshi ·Hiroki Odagiri, (unknown), Masafumi Fujii, Masahiro Fujita, (unknown), Kentaro Ono, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact